Skip to main content
PMC home page
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2018 Mar 23;9:261. doi: 10.3389/fphar.2018.00261

Anti-gout Potential of Malaysian Medicinal Plants

Fazleen I Abu Bakar 1,2, Mohd F Abu Bakar 1,2,*, Asmah Rahmat 1,*, Norazlin Abdullah 1, Siti F Sabran 1,2, Susi Endrini 3
PMCID: PMC5876239  PMID: 29628890

Abstract

Gout is a type of arthritis that causes painful inflammation in one or more joints. In gout, elevation of uric acid in the blood triggers the formation of crystals, causing joint pain. Malaysia is a mega-biodiversity country that is rich in medicinal plants species. Therefore, its flora might offer promising therapies for gout. This article aims to systematically review the anti-gout potential of Malaysian medicinal plants. Articles on gout published from 2000 to 2017 were identified using PubMed, Scopus, ScienceDirect, and Google Scholar with the following keyword search terms: “gout,” “medicinal plants,” “Malaysia,” “epidemiology,” “in vitro,” and “in vivo.” In this study, 85 plants were identified as possessing anti-gout activity. These plants had higher percentages of xanthine oxidase inhibitory activity (>85%); specifically, the Momordica charantia, Chrysanthemum indicum, Cinnamomum cassia, Kaempferia galanga, Artemisia vulgaris, and Morinda elliptica had the highest values, due to their diverse natural bioactive compounds, which include flavonoids, phenolics, tannin, coumarins, luteolin, and apigenin. This review summarizes the anti-gout potential of Malaysian medicinal plants but the mechanisms, active compounds, pharmacokinetics, bioavailability, and safety of the plants still remain to be elucidated.

Keywords: xanthine oxidase inhibition, anti-gout, phytochemical, Malaysian medicinal plants, in vitro, in vivo

Background

Gout incidence has increased over the past 50 years, especially in developing countries (Kuo et al., 2015). Gout is a type of inflammatory arthritis triggered by interactions between monosodium urate (MSU) crystals and tissue (Dalbeth et al., 2014) during purine catabolism by the enzyme of xanthine oxidase (Nile et al., 2013). Xanthine oxidase catalyzes the oxidative hydroxylation of hypoxanthine to xanthine to uric acid, leading to painful inflammation (Nile and Khobragade, 2011). Uricase is an enzyme that further catalyzes the conversion of uric acid to the highly soluble allantoin that is excreted in the urine (Figure 1). Unfortunately, uricase is not a functional human enzyme and, as a result, humans can develop hyperuricemia (Gliozzi et al., 2016). Gout has also been reported to cause tophi, joint deformities, and kidney stones (Teh et al., 2014).

Figure 1.

Figure 1

Open in a new tab

Mechanism of purine catabolism (Offermanns and Rosenthal, 2008; Bustanji et al., 2011).

Hyperuricemia, a major etiological factor of gout, develops either due to overproduction caused by a metabolic disorder or due to under excretion of blood uric acid due to abnormal renal urate transport activity (Ichida et al., 2012). Kidney is the main regulator of serum uric acid levels where renal urate excretion is determined by the balance of the reabsorption and secretion of urate. Renal urate reabsorption is mainly mediated by two urate transporters—urate transporter 1 (URAT1) and glucose transporter 9 (GLUT9) (Enomoto et al., 2002; Matsuo et al., 2008). One of the mechanisms involved in reducing the plasma uric acid concentration is an inhibition of the reabsorption of urate in renal tissue via renal mRNA and protein levels of urate transporter 1 (URAT1), glucose transporter 9 (GLUT9), organic anion transporter 1 (OAT1) and organic cation/carnitine transporters (OCT1/2, OCTN1/2) (Sungthong et al., 2016). Hyperuricemia occurs when serum uric acid levels are >0.42 mmol/L (Stamp et al., 2007). Therefore, reducing uric acid is the main approach for the treatment of gout, with target levels of serum uric acid of less than 0.36 mmol/L (Falasca, 2006; Pillinger et al., 2007).

Several risk factors for the development of gout have been established, including hyperuricemia, age, genetic factors, dietary factors, alcohol consumption, metabolic syndrome, hypertension, obesity, diuretic use, cholesterol level, and chronic renal disease (Roddy and Doherty, 2010). Men are believed to have four- to nine-fold increased the risk of developing gout compared to women; however, once women reach menopause, they tend to develop gout, as the uricosuric action of estrogen is lost (Tausche et al., 2009). Genetics and race may also be important factors that contribute to the incidence of gout (Mohd et al., 2011).

Several drugs are approved for the treatment of gout, including colchicine, steroids, non-steroidal anti-inflammatory drugs (ibuprofen, naproxen, indomethacin, and aspirin), cyclooxygenase 2 (COX-2) inhibitors (etoricoxib), and allopurinol. Although these agents are effective, they also cause side effects, such as skin allergies, fever, rash, renal dysfunction, aseptic meningitis, and hepatic dysfunction (Nguyen et al., 2004; Strazzullo and Puig, 2007). For example, allopurinol, which is the most commonly used xanthine oxidase inhibitor for gout (Pacher et al., 2006), causes nephrolithiasis, hypersensitivity reaction, Stevens-Johnson syndrome, renal toxicity, allergic reactions, and fatal liver necrosis, and increases the toxicity of 6-mercaptopurin (Kong et al., 2004; Wang et al., 2004).

Recently, treating disease using medicinal plants is gaining new interest (Unno et al., 2004) and research on medicinal plants has increased worldwide (Tapsell et al., 2006; Triggiani et al., 2006) due to fewer side effects and lower costs (Srivastava et al., 2012). Malaysia is a country that has more than 8,000 species of flowering plants and ~7,411 plant species have been identified in Sabah, Malaysia Borneo; in addition, 1,300 medicinal plant species have been documented in Peninsular, Malaysia (Kulip, 2003; Abd Aziz et al., 2011). The aim of the present review is to provide comprehensive information on the potential of anti-gout Malaysian medicinal plants and review the scientific data, including the experimental methodologies, active compounds, and mechanisms of action against gout.

Methods

PubMed, Scopus, ScienceDirect and Google Scholar databases were searched for publications from 2000 to 2017 with in vitro and in vivo data on Malaysian medicinal plants for gout. The search terms included the following: “gout,” “medicinal plants,” “in vivo,” “in vitro,” “epidemiology,” “Malaysia,” and “mechanisms.” Publications with available abstracts were also reviewed and ~99 publications, including journal articles and proceedings, were reviewed. Data from these studies were then were summarized (Table 1: in vitro data; Table 2: in vivo data).

Table 1.

The medicinal plants which are considered to possess anti-gout activity based on in vitro studies.

Scientific name Family Local name Part/Solvent used IC50 (μg/ml) Xanthine oxidase inhibition Active compounds Reference(s)
Acorus calamus Araceae Pokok jerangau Rhizome/Methanol 89.2 55.10% at 100 μg/ml NA Nguyen et al., 2004
Adenanthera payonina Leguminosae Saga Leaves/Methanol NA 47.15% at 100 μg/ml Cardiac glycosides Apaya and Chichioco-Hern, 2011
Allium ampeloprasum Liliaceae Bawang perai Leaves/Ethanol NA 43.71% at 100 μg/ml NA El-Rahman and Abd–Elhak, 2015
Alpinia galanga Zingiberaceae Lengkuas Rhizome/Ethanol NA 57.99% at 100 μg/ml NA Yumita et al., 2013
Annona muricata Annonaceae Durian belanda Leaves/Ethanol >200 14.18% at 100 μg/ml NA Sunarni et al., 2015
Annona reticulata Annonaceae Lonang, Nona kapri Leaves/Ethanol 171.73 47.38% at 100 μg/ml NA Sunarni et al., 2015
Annona squamosa Annonaceae Buah nona Leaves/Ethanol >200 6.37% at 100 μg/ml NA Sunarni et al., 2015
Apium graveolens Apiaceae Saderi Leaves/Ethanol NA 73.89% at 100 μg/ml NA El-Rahman and Abd–Elhak, 2015
Leaves/Methanol NA 37.92% at 100 μg/ml Alsultanee et al., 2014
Artemisia vulgaris Asteraceae Baru cina Leaves/Methanol 14.7 89.30% at 100 μg/ml Flavonoids Nguyen et al., 2004
Averrhoa carambola Oxalidaceae Belimbing manis Leaves /Ethanol NA 23.61% at 100 μg/ml NA Azmi et al., 2012
Flowers/Ethanol 2.47% at 100 μg/ml
Ripe fruit peels/ethanol 7.11% at 100 μg/ml
Barleria prionitis Acanthaceae Bunga landak Folium/Ethanol NA 1.73% at 100 μg/ml NA Yumita et al., 2013
Barringtonia racemosa Lecythidaceae Putat Leaves/Methanol NA 58.82% at 1,000 μg/ml NA Osman et al., 2016
Endosperm/Methanol 57.20% at 1,000 μg/ml
Pericarp/Methanol 57.99% at 1,000 μg/ml
Infloresence axis/Methanol 59.54% at 1,000 μg/ml
Blumea balsamifera Asteraceae Pokok Sembung, capa, telinga kerbau Leaves/Methanol 0.111 NA Flavonoids Nessa et al., 2010
6.0 80.90% at 100 μg/ml NA Nguyen et al., 2004
Brassica oleracea Brassicaceae Kubis merah Leaves/Water 230,150.00 53.72% at 250 mg/ml Phenolic acids, anthocyanins Al-Azzawie and Abd, 2015
Butea monosperma Fabaceae Palasa Roots/Methanol 5.0 75.00% at 100 μg/ml NA Nile and Park, 2014
Caesalpinia sappan Caesalpiniaceae Sepang Wood/Methanol 14.2 78.50% at 100 μg/ml NA Nguyen et al., 2004
Calophyllum inophyllum Calophyllaceae Penaga laut Leaves/Methanol NA 25.63% at 100 μg/ml Phenolic, tannins, flavonoids Apaya and Chichioco-Hern, 2011
Cantella asiatica Umbelliferae Pegaga Whole plant/Methanol NA 27.20% at 100 μg/ml NA Nguyen et al., 2004
41.00% at 100 μg/ml NA Kong et al., 2000
Carica papaya Caricaceae Betik Leaves/Ethanol NA 78.38% at 100 μg/ml NA Azmi et al., 2012
Petioles/Ethanol 8.11% at 100 μg/ml
Seeds/Ethanol 19.82% at 100 μg/ml
Unripe fruits/Ethanol 68.47% at 100 μg/ml
Flowers/Ethanol 66.03% at 100 μg/ml
Unripe fruit peels/ethanol 71.17% at 100 μg/ml
Cassia fistula Fabaceae kayu raja Leaves/Methanol NA 61.90 % at 100 μg/ml Alkaloid, tannins Apaya and Chichioco-Hern, 2011
Seeds/Methanol 64.56% at 100 μg/ml Jothy et al., 2011
Chrysanthemum indicum Asteraceae Bunga kekwa Flower/Methanol 22 95.00% at 100 μg/ml Luteolin and apigenin Kong et al., 2000
Chrysanthemum sinense Asteraceae Teh bunga Flower/Methanol 5.1 82.90% at 100 μg/ml Caffeic acid, luteolin, eriodictyol Nguyen et al., 2004
Cinnamomum cassia Lauraceae Kayu manis cina Twig/Methanol 18 93.00% at 100 μg/ml Eugenol Kong et al., 2000; Nguyen et al., 2004
Bark/Methanol 58 89.00% at 100 μg/ml
82.4 55.80% at 100 μg/ml
Cinnamomum cinnamon Lauraceae Kayu manis Leaves/Methanol NA 44.34% at 100 μg/ml NA Alsultanee et al., 2014
Citrullus colocynthis Cucurbitaceae Tembikai Seeds/water NA 14.40% at 200 μg/ml NA Bustanji et al., 2011
Citrus sinensis Rutaceae Oren Fruit shell/Methanol NA 51.00% at 100 μg/ml NA Kong et al., 2000
Clinacanthus nutans Acanthaceae Belalai gajah Aerial part/Ethanol 10 NA NA Tu et al., 2014
Cucurbita pepo Cucurbitaceae Labu Seeds/methanol NA 27.33% at 100 μg/ml NA Alsultanee et al., 2014
Curcuma longa Zingiberaceae Kunyit Whole plant/methanol NA 28.31% at 100 μg/ml NA Alsultanee et al., 2014
Cymbopogon citratus Poaceae Serai makan Stalks/Eessential oil NA 81.34% at ratio of volume concentration of essential oil per volume of solvent, 1:2 NA Mirghani et al., 2012
Cymbopogon nardus Poaceae Serai wangi Petiolum/Ethanol NA 18.12% at 100 μg/ml NA Yumita et al., 2013
Cyperus rotundus Cyperaceae Rumput halia hitam Rhizome/Methanol 52.9 79.40% at 100 μg/ml NA Nguyen et al., 2004
Dimocarpus longan Sapindaceae Longan Flower/Ethyl acetate 115.8 78.60% at 100 μg/ml Proanthocyanidin A2, Acetonylgeraniin A Sheu et al., 2016
Pericarps/Ethyl acetate 118.9 79.20% at 50 μg/ml
Twigs/Ethyl acetate 125.3 79.20% at 50 μg/ml
Seeds/Ethyl acetate 262.5 78.90% at 50 μg/ml
Leaves/Ethyl acetate 331.1 42.10% at 100 μg/ml
Dimocarpus longan malesianus Sapindaceae Mata kucing, Longan hijau Sarawak Leaves/Ethanol NA 46.88% at 100 μg/ml NA Azmi et al., 2012
Ripe fruit peels/Ethanol 13.41% at 100 μg/ml
Erythrina indica Fabaceae Dedap batik Bark/Methanol 52.75 NA Phenolic Sowndhararajan et al., 2012
Erythrina stricta Fabaceae Bunga dedap Leaves/Chloroform fraction 21.20 NA Phenolic and flavonoid Umamaheswari et al., 2009
Leaves/Ethyl acetate fraction 44.90
Glycyrrhiza uralensis Fabaceae Akar manis Root/Methanol 54.9 64.40% at 100 μg/ml NA Nguyen et al., 2004
Hedyotis diffusa Rubiaceae Rumput lidah ular Aerial part/Methanol 78.9 55.90% at 100 μg/ml NA Nguyen et al., 2004
Hibiscus sabdariffa Malvaceae Asam susur Calyx/Water NA 19.40% at 200 μg/ml NA Bustanji et al., 2011
Calyx/Ethanol NA 27.12% at 200 μg/ml NA Wahyuningsih et al., 2016b
Justicia gendarussa Acanthaceae Daun rusa Folium/Ethanol NA 18.48% at 100 μg/ml NA Yumita et al., 2013
Kaempferia galangal Zingiberaceae Cekur Rhizome/Ethanol NA 28.86% at 100 μg/ml NA Yumita et al., 2013
Rhizome/Methanol 53.4 90.60% at 100 μg/ml NA Nguyen et al., 2004
Kalanchoe pinnata Crassulaceae Setawar Aerial part/Methanol 40.8 68.10% at 100 μg/ml NA Nguyen et al., 2004
Lantana camara Verbenaceae Bunga tahi ayam Folium/Ethanol NA 17.17% at 100 μg/ml NA Yumita et al., 2013
Manilkara zapota Sapotaceae Duku Leaves/Ethanol NA 70.81% at 100 μg/ml NA Azmi et al., 2012
Peels/Ethanol 41.03% at 100 μg/ml
Seeds/Ethanol 11.81% at 100 μg/ml
Melaleuca leucadendra Myrtaceae Gelam, kayu putih Stem and fruit/Methanol 76.7 64.60% at 100 μg/ml NA Nguyen et al., 2004
Mimosa pudica Leguminosae Semalu Leaves/Methanol NA 62.36% at 100 μg/ml Flavonoids, phenolic Nguyen et al., 2004; Apaya and Chichioco-Hern, 2011
Aerial part/Methanol 52.7 65.50% at 100 μg/ml
Momordica charantia Cucurbitaceae Peria Pulp/Methanol NA 96.50% at 100 μg/ml Flavonoid, tannin, coumarins, glycoside Kong et al., 2000; Alsultanee et al., 2014
Seed/Methanol 45.00% at 100 μg/ml
Morinda citrifolia Rubiaceae Mengkudu jantan/mengkudu besar/noni Fruit/Methanol NA 64.00% at 0.1 mg/ml NA Palu et al., 2009
Morinda elliptica Rubiaceae Mengkudu hutan/mengkudu tahi ayam Leaves/Methanol NA 88.93% at 100 μg/ml NA Jamal et al., 2014
Olea europaea Oleaceae Zaitun Leaves/Water 114,020.00 80.00% at 250 mg/ml Oleuropein, apigenin, luteolin, caffeic acid Al-Azzawie and Abd, 2015;Flemmig et al., 2011
Leaves/Ethanol 42 60.00% at 50 μg/ml
Orthosiphon stamineus Lamiaceae Misai kucing Leaves/Ethanol 92.4 68.59% at 100 μg/ml NA Nguyen et al., 2004; Hendriani et al., 2016
Aerial part/Methanol NA 37.60% at 100 μg/ml
Petroselinum crispum Apiaceae Daun sup Leaves/Ethanol NA 82.57% at 100 μg/ml NA Alsultanee et al., 2014; El-Rahman and Abd–Elhak, 2015
Leaves/Methanol 28.63% at 100 μg/ml
Phaleria macrocarpa Thymelaeaceae Mahkota dewa Leaves/Methanol NA 34.83% at 100 μg/ml Phalerin Fariza et al., 2012
Phaseolus vulgaris Papilinaceae Kacang buncis Fruit/Water >300 26.00% at 300 μg/ml Flavonoids Roohbakhsh et al., 2009
Pimpinella anisum Apiaceae Jintan manis Fruit/Water 300.4 35.60% at 200 μg/ml NA Bustanji et al., 2011
Piper betle Piperaceae Sireh Leaves/Ethanol 16.7 NA 4-allyl-1,3-hydroxychavicol Murata et al., 2009
Plantago major Plantaginaceae Ekor anjing, daun sendok Folium/Ethanol NA 21.70% at 100 μg/ml NA Yumita et al., 2013
Radix/Ethanol 3.66% at 100 μg/ml
Plumbago zeylanica Plumbaginaceae Celaka putih, celaka bukit Roots/Methanol 5 65.40% at 100 μg/ml NA Nile and Park, 2014
Pogostemon cablin Lamiaceae Pokok Nilam Leaves/Methanol NA 33.16% at 100 μg/ml NA Apaya and Chichioco-Hern, 2011
Portulaca oleracea Portulacaceae Gelang pasir Leaves/Methanol NA 39.00% at 100 μg/ml Flavonoids, phenolic, tannins Apaya and Chichioco-Hern, 2011
Punica granatum Lythraceae Buah delima Seed/Methanol NA 15.53% at 100 μg/ml NA Wong et al., 2014
Salacca zalacca Arecaceae Salak Leaves/Ethanol NA 19.66% at 100 μg/ml NA Azmi et al., 2012
Pulps/Ethanol 2.88% at 100 μg/ml
Ripe fruit peels/ethanol 12.85% at 100 μg/ml
Senna alata Fabaceae Gelenggang Leaves/Methanol NA 71.00% at 100 μg/ml Kaempferol Fadzureena et al., 2013
Synsepalum dulcificum Sapotaceae Buah ajaib Fruit/Ethyl acetate NA 80.00% at 10 mg/ml NA Shi et al., 2016
Tamarindus indica Fabaceae Asam jawa Pulp/Ethanol NA 21.40% at 100 μg/ml NA Yumita et al., 2013
Lignum/Ethanol 44.90% at 100 μg/ml
Tetracera scandens Dilleniaceae Mempelas kasar Root and stem/methanol 33.3 73.60% at 100 μg/ml NA Nguyen et al., 2004
Tinospora rumphii Menispermaceae Petawali Leaves/Methanol NA 39.99% at 100 μg/ml Alkaloids, terpenoids, tannins, cardiac glycosides Apaya and Chichioco-Hern, 2011
Trachelospermum jasminoides Apocynaceae Melur hutan Stem/Methanol 108 51.00% at 100 μg/ml NA Kong et al., 2000
Vitex negundo Lamiaceae Lenggundi Leaves/Methanol NA 50.42% at 100 μg/ml Flavonoids, steroids, tannins, terpenoids Apaya and Chichioco-Hern, 2011; Nile and Park, 2014
Roots/Methanol 6 70.00%
Woodfordia floribunda Lythraceae Seduayah Flos/Ethanol NA 55.33% at 100 μg/ml Flavonoids Yumita et al., 2013
Zingiber officinale Zingiberaceae Halia Rhizome/Methanol 10.5 μM of 6-gingerol value NA NA Alsultanee et al., 2014
Rhizome/Water NA 81.56% at 100 μg/ml Nile and Park, 2014
99,370 87.97% at 250 mg/ml Al-Azzawie and Abd, 2015
Open in a new tab

IC50 value is based on the type of solvent used in the extraction.

NA = data is not available.

Table 2.

The medicinal plants which are considered to possess anti-gout activity based on in vivo studies.

Scientific name Family Local name Part/solvent used Dose of the extract Experimental animal model Main outcomes References
Allium ampeloprasum Liliaceae Bawang perai Leaves/Water 5 g/kg body weight Male albino hyperuricemia rats induced by potassium oxonate Serum uric acid levels of hyperuricemic rats reduced significantly El-Rahman and Abd–Elhak, 2015
Allium cepa Amaryllidaceae Bawang merah Edible portion/Water 5 g/kg body weight Wistar hyperuricemia rats induced by potassium oxonate Serum uric acid levels of hyperuricemic rats reduced significantly after 14 days of treatment/onion resulted in significant inhibition on liver of xanthine oxidase activity (39.75%) Haidari et al., 2008
Annona muricata Annonaceae Durian belanda Leaves/Ethanol 75 mg/kg body weight Male Wistar hyperuricemia rats induced by potassium oxonate Serum uric acid level in oxonate-induce rats reduced significantly Sunarni et al., 2015
100, 200, and 400 mg/kg of body weight Wistar hyperuricemia rats induced by potassium oxonate All doses reduced serum uric acid levels of hyperuricemic rats by 63.98, 86.29, and 61.50%, respectively Sri-Wahjuni et al., 2012
Annona reticulata Annonaceae Lonang, Nona kapri Leaves/Methanol 75 mg/kg body weight Male Wistar hyperuricemia rats induced by potassium oxonate Serum uric acid level in oxonate-induce rats reduced significantly Sunarni et al., 2015
Annona squamosa Annonaceae Buah nona Leaves/Ethanol 75 mg/kg body weight orally Male Wistar hyperuricemia rats induced by potassium oxonate Serum uric acid level in oxonate-induce rats reduced significantly Sunarni et al., 2015
Apium graveolens Apiaceae Saderi Leaves/Water 5 g/kg body weight Male albino hyperuricemia rats induced by potassium oxonate Serum uric acid levels of hyperuricemic rats reduced significantly El-Rahman and Abd–Elhak, 2015
Seeds/Petroleum ether 500 mg/kg rat body weight Male Sprague-Dawley hyperuricemia rats induced by potassium oxonate Produced the highest reduction (56%) in uric acid level in urine Mohamed and Al-Okbi, 2008
Cinnamomum zeylanicum Lauraceae Kayu manis Bark/Petroleum ether 500 mg/kg rat body weight Male Sprague-Dawley hyperuricemia rats induced by potassium oxonate Produced the reduction (47%) in uric acid level in urine Mohamed and Al-Okbi, 2008
Cooccinia drandi Cucurbitaceae Timun padang, pepasan Leaves/Methanol 200 mg/kg body weight oral per day Swiss albino hyperuricemia mice induced by potassium oxonate Serum urate level reduced significantly up to 3.90 ± 0.07 mg/dl Umamaheswari et al., 2007
Dimocarpus longan Sapindaceae Longan Flower, pericarp, seed, leaf, and twig/methanol 50, 75, and 100 mg/kg of body weight Male ICR hyperuricemia mice induced by potassium oxonate Plasma urate levels of hyperuricemic mice reduced significantly in dose-dependent manner Sheu et al., 2016
Seed/Water 80 mg/kg of body weight for crude extract Male Sprague-Dawley hyperuricemia rats induced by potassium oxonate and hypoxanthine Serum uric acid level and xanthine oxidase activity reduced significantly. However, the extract increased xanthine oxidase activities in liver Hou et al., 2012
Emblica officinalis Euphobiaceae Pokok melaka Triphala powder, an Indian ayurvedic herbal formulation) (mixture of dried and powdered fruits of the three plants in equal proportions) 1 g/kg body weight oral per day Monosodium urate crystal-induced inflammation in Swiss albino mice Triphala treatment decreased the paw diameter significantly in monosodium urate crystal-induced mice Sabina and Rasool, 2008
Epiphyllum oxypetalum Cactaceae Bakawali Leaves/Ethanol and water 200, 400, 600 mg/kg body weight Carrageenan induced adult rats of Albino Wistar strain paw edema Percentage inhibition of rat paw edema by alcohol and aqueous extracts was 75.44 and 82.14% at dose of 600 mg/kg at 3 h Dandekar et al., 2015
Erythrina stricta Fabaceae Bunga dedap Leaves/Petroleum ether, chloroform, and ethyl acetate fractions 200 mg/kg body weight orally Hyperuricemia Swiss albino mice induced by potassium oxonate Produced significant reduction in serum urate levels and elicited significant inhibitory actions on xanthine oxidase/xanthinedehydrogenase enzyme activities in the mouse liver Raju et al., 2012
Hibiscus sabdariffa Malvaceae Asam susur Calyx/Water 1, 2, and 5% of H. sabdariffa extract Male Sprague-Dawley hyperuricemia rats induced by oxonic acid Extract significantly lowered uric acid by increasing uricase activity to promote uric acid excretion Kuo et al., 2012
Calyx/Ethanol extract, ethyl acetate fraction and water fraction 40 and 80 mg/kg body weight Male Wistar hyperuricemia rats induced by potassium oxonate The extract showed a significant reduction in serum uric acid leveland had uricosuric effect that increased the excretion of uric acid in urine significantly Wahyuningsih et al., 2016a
Jatropha curcas Euphorbiaceae Pokok jarak Roots/Methanol 100 and 200 mg/kg orally Carrageenan induced Swiss albino mice and the Wister rat paw edema There were dose-dependant significant reduction in carrageenan-induced rat paw edema at 100 and 200 mg/kg of extract Mujumdar and Misar, 2004
Leonurus sibiricus Lamiaceae Pokok padang deman Leaves/Water 50, 100, and 200 mg/kg orally Sprague–Dawley hyperuricemia rats induced by oteracil potassium Extract reduced serum uric acid and creatinine levels of hyperuricemia rats and promote the excretion of uric acid of kidney Yan et al., 2014
Mangifera indica Anacardiaceae Mangga Leaves/Ethanol 100 and 200 mg/kg body weight by oral per day for crude extract Monosodium urate (MSU) crystals-induced gouty arthritis male Sprague-Dawley rats Extract significantly decreased ankle swelling in monosodium urate (MSU) crystal-induced gouty arthritis rats Jiang et al., 2012
Orthosiphon stamineus Lamiaceae Misai kucing Leaves/Methanol 0.5, 1, and 2 g/kg body weight Male Sprague-Dawley hyperuricemia rats induced by potassium oxonate Extract reduced the serum urate level inhyperuricemic rats at hour 6 and showed a significant increase in urine volume and electrolytes excretion Arafat et al., 2008
Peperomia pellucida Piperaceae Ketumpangan air/sireh cina Whole plant with flower petroleum ether 1,000 mg/kg body weight oral per day Carrageenan induced male Sprague Dawley rats hind paw edema Extract showed significant in magnitude of swelling 4 h following carrageenan administration Mutee et al., 2010
Petroselinum crispum Apiaceae Daun sup Leaves/Water 5 g/kg body weight Male albino hyperuricemia rats induced by potassium oxonate Serum uric acid levels of hyperuricemic rats reduced significantly El-Rahman and Abd–Elhak, 2015
Phyllanthus emblica Phyllanthaceae Pokok Melaka Fruit/Alcoholic and water 200 and 400 mg/kg of body weight Male Sprague-Dawley hyperuricemia rats induced by potassium oxonate Both extracts showed reduction in platelets counts, serum creatinine, uric acid, blood urea nitrogen and xanthine oxidase enzyme level Sarvaiya et al., 2015
Phyllanthus niruri Phyllanthaceae Dukung anak Leaves/Methanol 50 mg/kg body weight oral per day Male Sprague-Dawley hyperuricemia rats induced by potassium oxonate Extract increased urinary uric acid excretion and exhibited a significant 76.84% inhibition of xanthine oxidase activity Murugaiyah and Chan, 2009
Piper nigrum Piperaceae Lada hitam Piperine (active compounds) 30 mg/kg body weight oral per day Monosodium urate crystal-induced inflammation in Swiss albino mice Piperine decreased the paw diameter significantly in monosodium urate crystal-induced mice Sabina et al., 2011
Premna serratifolia Lamiaceae Buas- buas Wood without bark/ethanol extract 300 mg/kg body weight orally per day for 14 days Bacteria induced Wistar albino rats hind paw edema Extract inhibited the rat paw edema by 68.32% after 21 days Rajendran and Krishnakumar, 2010
Synsepalum dulcificum Sapotaceae Buah ajaib Fruit/Butanol 500–1,000 mg/kg body weight per day orally Male ICR hyperuricemia mice induced by oxonic acid potassium salt Extract lowered serum uric acid levels and activated hepatic xanthine oxidase Shi et al., 2016
Zingiber officinale Zingiberaceae Halia Rhizome/Water 50 and 100 mg/kg of body weight Hyperuricemia rats induced by potassium oxonate Extract reduced the uric acid levels significantly in hyperuricemic rats after 14 days Al-Azzawie and Abd, 2015
Zingiber zerumbet Zingiberaceae Halia hutan, Lempoyang Rhizome/mixture of hexane and ethyl acetate 10 and 20 mg/kg of body weight Carrageenan induced female Sprague dawley rats hind paw edema 10 and 20 mg/kg zerumbone exhibited significant maximum inhibition of 45.67 and 70.37%, respectively Somchit et al., 2012
Open in a new tab

Discussion

Medicinal plants contain many bioactive compounds and antioxidants that can be used as complementary or alternative medicines to treat gout. In fact, ~65–80% of people in developing countries use medicinal plants as remedies (World Health Organization, 2011). Plants are also important sources of medicines in the United States, where at least one plant-based ingredient is used in 25% of pharmaceutical prescriptions (Kumar and Azmi, 2014).

The xanthine oxidase inhibition assay is considered a gold standard to study the anti-gout potential of medicinal plants. Some plants and their phytochemicals are worthy of exploration as they can act as xanthine oxidase inhibitors. These compounds are also safe if an appropriate amount is taken and have few side effects (Rates, 2001; Abd Aziz et al., 2011). Previous studies have reported that five vegetables contain possible agents that can cause acute or chronic toxicities when consumed in large quantities or over a long period of time (Orech et al., 2005). Thus, it is very important for researchers to evaluate the toxicity of plants in in vitro and in vivo studies and clinical trials.

In this study, ~46 families of plants were identified and studied, both in vitro (n = 30) and in vivo (n = 24), for anti-gout activity (Tables 1, 2). Plants from the Asteraceae, Cucurbitaceae, Fabaceae, Lamiaceae, and Zingiberaceae families have been studied extensively. Momordica charantia, from the Cucurbitaceae, had the highest in percentage of xanthine oxidase inhibitory activity of 96.5% at 100 μg/mL using 70% methanol extract (Alsultanee et al., 2014); the total phenolic content of this plant was 80.83 ± 0.30 mg gallic acid equivalent/100 g. Further phenolic compound analysis revealed the presence of phenolic compounds, including tannin, coumarin, flavonoid, and glycoside; among these, coumarine had the strongest inhibitory activity (97.29 %) against xanthine oxidase (Alsultanee et al., 2014). Other studies have suggested that this activity is due to the presence of bioactive phenolic compounds, such as polyphenols, tocopherols, and alkaloids, in the pulp of the plant (Tan et al., 2008). However, other plants in this family, such as Cucurbita pepo and Citrullus colocynthis, have lower xanthine oxidase inhibition values of 27.33% at 100 μg/mL and 14.40% at 200 μg/mL, respectively (Bustanji et al., 2011; Alsultanee et al., 2014).

In the Zingiberaceae family, Kaempferia galanga had the highest xanthine oxidase inhibitory activity at 100 μg/mL (90.6%), followed by Zingiber officinale (81.56%), Alpinia galanga (57.99%), and Curcuma longa (28.31%) (Nguyen et al., 2004; Yumita et al., 2013; Alsultanee et al., 2014). Yumita et al. (2013) also studied K. galanga but the results were in contrast to other studies (28.86%). These contrary results could be due to the different localities (Vietnam and Indonesia), although both studies employed similar drying methods. Moderate total phenolic content was found in Z. officinale, with a value of 62.18 ± 0.65 mg gallic acid equivalent/100 g (Alsultanee et al., 2014).

Plants from the Asteraceae family include Artemisia vulgaris, Blumea balsamifera, Chrysanthemum indicum, and Chrysanthemum sinense, of which C. indicum exhibited 95% xanthine oxidase inhibitory activity at 100 μg/mL. The isolated flavonoid compounds from the flower of C. indicum, namely luteolin and apigenin, may act as xanthine oxidase inhibitors (Kong et al., 2000). Moreover, C. sinense also had higher xanthine oxidase inhibitory activity (82.90%) at 100 μg/mL with an IC50 value of 5.1 μg/mL (Nguyen et al., 2004). Further isolation of the active compounds from the flower of C. sinense led to the identification of caffeic acid, luteolin, eriodictyol, and 1,5-di-O-caffeoylquinic acid, which, among them, luteolin displayed more potent inhibitory activity compared to the positive control allopurinol, with IC50 values of 1.3 and 2.5 μM, respectively (Nguyen et al., 2004). A. vulgaris also exhibited higher xanthine oxidase inhibitory activity of 89.30% at 100 μg/mL (Nguyen et al., 2004).

Method of extraction is considered an important factor that affects xanthine oxidase inhibitory activity. The type of solvents used also contributes to differences in compounds extracted from the plants. El-Rahman and Abd–Elhak (2015) and Alsultanee et al. (2014) reported similar results on the ethanol and methanol extracts of Petroselinum crispum, with inhibition values of 82.57 and 28.63%, respectively. In contrast, Alsultanee et al. (2014) and Al-Azzawie and Abd (2015) reported that both the methanol and aqueous extracts of Z. officinale had similar xanthine oxidase inhibition percentages, with values of 81.56% and 87.97%, respectively. In addition, Azmi et al. (2012) reported that both methanol and ethanol had a higher capacity to extract xanthine oxidase inhibitors from all parts of plants; 25% of all plant extracts showed more than 50% inhibition using these two solvents compared to distilled water with only 20% of all plant extracts showing more than 50% xanthine oxidase inhibitory activity. In another study, methanol extract was found to be more active than hydroalcoholic and aqueous extracts (Nguyen et al., 2004; Umamaheswari et al., 2007). Even though methanol and ethanol extracts have higher rates of xanthine oxidase inhibitory activity, safety is the main concern of the pharmaceutical industry. Alcohol is a nervous system depressant that impairs the transmission of nerve signals, ultimately leading to respiratory suppression (Bailey and Bailey, 2000). Methanol is a highly poisonous solvent that can upset the acid-base balance of body (Azmi et al., 2012). Therefore, identifying a less toxic solvent is important.

Based on results of xanthine oxidase inhibitory activity analysis, the following plants showed more than 85% activity at 100 μg/mL: M. charantia (96.50%), C. indicum (95.00%), Cinnamomum cassia (93.00%), K. galanga (90.60%), A. vulgaris (89.30%), and Morinda elliptica (88.93%) (Kong et al., 2000; Nguyen et al., 2004; Alsultanee et al., 2014; Jamal et al., 2014). Of the other studied plants, three exhibited at least 80% activity, including C. sinense (82.90%), Z. officinale (81.56%), and B. balsamifera (80.90%) (Nguyen et al., 2004; Alsultanee et al., 2014; Jamal et al., 2014) at 100 μg/mL, while Olea europaea and Synsepalum dulcificum exhibited 80.00% activity at 250 mg/mL and 10 mg/mL, respectively (Al-Azzawie and Abd, 2015; Shi et al., 2016). IC50 values, the concentration at which half the xanthine oxidase activity is inhibited, were determined in a few studies. In this study, the lowest IC50 value was 0.111 μg/mL, indicating that B. balsamifera extract inhibited 50% of xanthine oxidase activity (Nessa et al., 2010).

A few studies further analyzed and isolated the bioactive compounds present in plants that exerted the highest xanthine oxidase inhibitory activity, allowing them to act as xanthine oxidase inhibitors by blocking the biosynthesis of uric acid from purine in the body (Unno et al., 2004). Please see the following examples: cardiac glycosides (Apaya and Chichioco-Hern, 2011), flavonoids (Nguyen et al., 2004; Roohbakhsh et al., 2009; Umamaheswari et al., 2009; Nessa et al., 2010; Apaya and Chichioco-Hern, 2011; Yumita et al., 2013), phenolics (Umamaheswari et al., 2009; Apaya and Chichioco-Hern, 2011; Sowndhararajan et al., 2012; Alsultanee et al., 2014; Al-Azzawie and Abd, 2015), anthocyanins (Al-Azzawie and Abd, 2015), tannins (Apaya and Chichioco-Hern, 2011), alkaloids (Apaya and Chichioco-Hern, 2011), proanthocyanidin A2 (Sheu et al., 2016), acetonylgeraniin A (Sheu et al., 2016), phalerin (Fariza et al., 2012), 4-allyl-1,3- hydroxychavicol (Murata et al., 2009), kaempferol (Fadzureena et al., 2013), terpenoids Apaya and Chichioco-Hern, 2011, luteolin (Kong et al., 2000; Nguyen et al., 2004; Flemmig et al., 2011), apigenin (Kong et al., 2000; Flemmig et al., 2011), caffeic acid (Nguyen et al., 2004; Flemmig et al., 2011), eriodictyol (Nguyen et al., 2004), oleuropein (Flemmig et al., 2011), luteolin-7-O–d-glucoside (Flemmig et al., 2011), and scopoletin (Ding et al., 2005). Until now, these bioactive compounds have not been further analyzed or developed into anti-gout medications.

Hyperuricemia has been modeled in pre-clinical studies by blocking uricase enzyme with potassium oxonate (Umamaheswari et al., 2007; Haidari et al., 2008). Administration of potassium oxonate (250 mg/kg) results in marked increases in serum uric acid level in rats (Shi et al., 2016). Several in vivo studies have demonstrated a reduction of serum uric acid levels in hyperuricemic rats. For example, administration of aqueous and alcoholic extracts of Phyllanthus emblica (200 and 400 mg/kg) reduced serum uric acid and xanthine oxidase enzyme levels in hyperuricemic rats while allopurinol was more potent in inhibiting xanthine oxidase enzyme (Sarvaiya et al., 2015). Similar results have also been reported by El-Rahman and Abd–Elhak (2015) for Allium ampeloprasum, Apium graveolens, and P. crispum using albino rats, where both extracts significantly reduced serum uric acid and lipid peroxidation and increased antioxidant enzyme activity levels at a dose of 5 g/kg. Phytochemical screening of the extracts also revealed their major constituents, which include phenolic (polyphenols, tocopherols, and alkaloids), flavonoids, and saponins that may act as xanthine oxidase inhibitors (Fejes et al., 2000; Zhou and Yu, 2006; Sreeramulu and Raghunath, 2010).

Some of the active compounds were isolated from the medicinal plants for investigating the underlying mechanisms of hypouricemic actions in rat model. Zeng et al. (2017) studied the bioavailability of scopoletin or 6-methoxy-7-hydroxycoumarin, a major active coumarin isolated from the stems of Erycibe obtusifolia and its hypouricemic effects in vivo. In this study, they encapsulated scopoletin into Soluplus micelles (Soluplus-based scopoletin micelles, Sco-Ms) in order to improve its oral bioavailability. To study the pharmacokinetics and biodistribution in vivo, the rats were orally administered with scopoletin suspension, physical mixtures of scopoletin and Soluplus (Sco-PM) and Sco-Ms at dose of 100 mg/kg scopoletin. At predetermined time intervals (2, 5, 10, 15, 20, 30, 45, 60, 90, and 120 min), the blood samples were collected for determining the plasma concentrations of scopoletin. Sco-Ms showed significantly higher maximum plasma concentration, Cmax of 14,674.796 ± 2,997.147 μg/L than scopoletin and Sco-PM at 10 min. Orally administered Sco-Ms was rapidly absorbed than Sco-PM and scopoletin, with a time to reach maximum plasma concentration, tmax of 0.167 h while the time taken for plasma concentration of Sco-Ms to reduce by 50% of its initial value, t1/2 was 0.468 h. Sco-Ms showed CL value (ability to clear drug from the bloodstream which usually by hepatic metabolism or renal excretion) of 28.703 ± 3.482 L.h−1.kg−1. Interestingly, Sco-Ms was found to have higher scopoletin concentration in liver than the scopoletin suspension which would be importance for the inhibition of hepatic xanthine oxidase activity. The hepatic and serum xanthine oxidase activity of hyperuricemic rats were investigated in order to determine the possible mechanism of the anti-hyperuricemic effect of Sco-MS. Based on the result obtained, the oral administration of Sco-Ms at dose of 300 mg/kg reduced the serum uric acid concentration to the normal level. In addition, Zhang et al. (2016) studied the biodistribution and hypouricemic efficacy of morin (3,5,7,2′,4′-pentahydroxyflavone), a yellow pigment present in the plants from the Moraceae family. In this study, they tested a novel self-nanoemulsifying drug delivery system based on morin-phospholipid complex (MPC-SNEDDS) in vivo which improved the oral bioavailability of morin. After the administration of morin suspension, the concentration of morin in liver was markedly higher than other tissues (e.g., heart, spleen, lung, and kidney) at 0.5, 1, and 4 h. Moreover, the morin concentration in the liver at 0.5 h after orally administered with MPC-SNEDDS (1,096 μg/mg) was three-fold higher than morin suspension (252 μg/mg) and thus, MPC-SNEDDS possessed more potent inhibitory effect on hepatic xanthine oxidase activity than morin. As expected, MPC-SNEDDS reduced serum uric acid level of hyperuricemic rats (145 μmol/l) to normal (45 μmol/l) at 6 h after oral administration. Hence, the hypouricemic effect of the active compounds (e.g., morin and scopoletin) may therefore be explained, at least in part, by a lowering of xanthine oxidase activity in rat liver.

Another possible mechanism to reduce plasma uric acid concentration is to inhibit the reabsorption of urate in renal tissue. In some studies, the mRNA and protein expression levels of the transporters responsible for urate reabsorption are examined in order to explore the underlying molecular mechanisms of uricosuric effects of active compounds or medicinal plants. For instance, mangiferin, an isolated compound from the leaves of Mangifera indica significantly decreased the mRNA and protein levels of URAT1 and GLUT9 in kidney of hyperuricemic rats, suggesting that it possessed the uricosuric action, which was associated to inhibiting reabsorption of urate (Yang et al., 2015). In other study, Dimocarpus longan Lour seed decreased GLUT9 protein level from the liver of the rat model (Hou et al., 2012). The ethanol extract of Ramulus mori, the branch of Morus alba possessed the uricosuric effects in hyperuricemic mice by down-regulating renal mURAT1 and mGLUT9 expression and up-regulating renal mOAT1 expression, which contributed to the enhancement of urate excretion and reduction of serum urate level as well as improved renal dysfunction in hyperuricemic rats by up-regulating renal expression of mOCT1, mOCT2, mOCTN1, and mOCTN2 (Shi et al., 2012). In cell culture model, stably hURAT1 transfected human epithelial kidney cell line was used by Zhang et al. (2017) to evaluate the ability of tigogenin (active metabolites of dioscin) in inhibiting 14C-uric acid uptake via hURAT1 and the result showed that this compound possessed significant inhibitory effect from 10 to 100 μM with a concentration-dependent manner and the uric acid permeability was significantly reduced to 60% at 100 μM.

The results of standard in vitro screening assays provided useful information to guide the next stage of investigation such as testing the plant extract in rodents. Administration of ethyl acetate fraction from a butanol extract of S. dulcificum resulted in 80% of xanthine oxidase inhibitory activity at 10 mg/mL; the effects of butanol extract from this fruit was similar to the results of an in vivo study using allopurinol (Shi et al., 2016). Al-Azzawie and Abd (2015) showed that the Z. officinale extract had the highest xanthine oxidase inhibition in vitro (87.97%) at 250 mg/mL; at both doses (100 and 250 mg/kg), ginger extract significantly reduced mean serum uric acid levels and inhibited xanthine oxidase activity in hyperuricemia rats.

Some studies have shown that different parts of the same plants can contribute differently to effects on uric acid levels. For example, methanol extracted from the D. longan flowers had a greater effect on lowering uric acid compared to the seeds due to the 10 phytochemicals in the flowers. Further analysis revealed that proanthocyanidin A2 and acetonylgeraniin have higher inhibitory activity against xanthine oxidase compared to allopurinol (Sheu et al., 2016). In addition, the ethanol extract from Hibiscus sabdariffa calyx, as well as ethyl acetate and water fractions, reduced uric acid levels in male Sprague-Dawley rats and Wistar rats, where the ethyl acetate fraction at a dose of 6.25 mg/kg demonstrated the best effect on uricosuric compared to water fraction and ethanol. Phytochemical screening of the ethanol extract of this plant also revealed the presence of flavonoid, saponin, polyphenol, and quinone (Wahyuningsih et al., 2016b). Monosodium urate crystal-induced inflammation in mice or rats is commonly used to study the anti-gout effect of plant extracts (Sabina and Rasool, 2008). Oral administration of triphala significantly reduced paw diameter at a dose of 1 g/kg body weight (Sabina and Rasool, 2008). Extracts from the M. indica leaf also significantly reduced ankle swelling in monosodium urate crystal-induced gout arthritis at a dose of 200 mg/kg across 8 h (Jiang et al., 2012).

In this study, we evaluated whether the doses used in in vitro and in vivo studies are physiologically relevant. In one study, administration of 250 mg/mL of Z. officinale extract resulted in high levels of xanthine oxidase inhibiton (87.97%) in vitro, while 250 mg/kg exhibited 57.14% of xanthine oxidase inhibition and significantly reduced serum uric acid levels (Al-Azzawie and Abd, 2015). In another study, S. dulcificum extract administration suppressed xanthine oxidase activity in MSU-treated RAW264.7 macrophages at 500 μg/mL, while a 1000 mg/kg dose in vivo reduced uric acid levels in rats (Shi et al., 2016). Methanol extracts from Phyllanthus niruri resulted in 67.66% inhibition at 100 μg/mL in an in vitro study and caused significant inhibition (76.84%) of xanthine oxidase activity at a 50 mg/kg dose in vivo (Murugaiyah and Chan, 2009). The results from these studies were very similar results in inhibiting xanthine oxidase activity, suggesting that the doses used were physiologically relevant.

Allopurinol, common drug used for gout patients, is approved by the US FDA for doses up to 800 mg/day for the treatment of hyperuricemia and gout (Chao and Terkeltaub, 2009). One study reported that gout patients attained target serum uric acid levels of <360 mmol/L at 300 mg/day of allopurinol, and that this dose was increased up to 600 mg/day in some patients; favorable results were observed as the dose increased and it was well tolerated, such that the therapeutic goal was achieved in 92.5% of patients. These doses are therefore well tolerated in those with well-preserved renal function (RadakPerović and ZlatkovićŠvenda, 2013). However, febuxostat, a non-purine selective xanthine oxidase inhibitor, at a daily dose of 80 mg or 120 mg was reported to be more effective than allopurinol (300 mg) in lowering serum urate levels (Becker et al., 2005).

Many plants used in in vivo studies, including Peperomia pellucida, Mangifera indica, Jatropha curcas, Epiphyllum oxypetalum, Zingiber zerumbet, Emblica officinalis, and Piper nigrum, have exhibited anti-inflammatory activities (Mujumdar and Misar, 2004; Mutee et al., 2010; Sabina et al., 2011; Somchit et al., 2012; Dandekar et al., 2015). In addition, zerombone, which is found in the rhizome of Zingiber zerumbet, may act as an anti-inflammatory agent similar to non-steroidal anti-inflammatory drugs (Somchit et al., 2012). It has been proposed that phenolic compounds, such as anthocyanins and quercetin, which are found abundantly in certain plants, can inhibit xanthine oxidase activity, as they are structurally related to xanthine (Mo et al., 2007). Additional studies must be conducted on the possible mechanisms of the anti-gout activity of these medicinal plants.

In addition, there are also human clinical trials performed in gout using plant based drugs. For instance, Prasongwatana et al. (2008) investigated the effects of roselle (H. sabdariffa) on urinary excretions of uric acid in human models with and without renal-stone history where they found the mean levels of uric acid clearance, uric acid excretion and fractional excretion of uric acid increased significantly after consuming H. sabdariffa tea and then decreased to baseline level (control) at the end of the washout period in both groups, suggesting its uricosuric effect provides a long-term benefit of hyperuricemia in gouty subjects. However, the chemical constituents responsible for the anti-gout effects in this plant yet to be fully elucidated. Furthermore, the same trend of results were observed in Orthosiphon stamineus tea where the consumption of this tea caused an increasing of uric acid excretion (Premgamone et al., 2001). It is well understood that the increase of uric acid excretion may result in urolithiasis (development of stones in the kidney due to supersaturation of the urine with stone-forming salts). As reviewed by Butterweck and Khan (2009), they gathered the information of few plants that have been studied for the management of urolithiasis such as H. sabdariffa, P. niruri, O. stamineus, Andrographis paniculata, Sambucus nigra, Solidago virgaurea, and Dolichos biflores. For instance, Nishiura et al. (2004) demonstrated that P. niruri extract reduced the uric acid level as well as normalized the urinary calcium levels in calcium stone forming patients. As mentioned above, many plants had been studied for the anti-urolithiasis rather than anti-gout activities. Furthermore, there is also a very limited number of clinical studies for the anti-gout activity as compared to in vitro and in vivo studies. To the best of our knowledge, there are no human studies on the anti-gout activity specifically to xanthine oxidase inhibitor mechanism. It is further suggested that pharmacologist and clinical investigators to conduct larger randomized clinical trials of longer duration in order to determine the efficacy of plant based drugs in the treatment of gout. The doses of the plant extract, method of extract preparation, and extraction solvent must also be taken into consideration.

Conclusion

This review summarized the potential of Malaysian medicinal plants treat gout based on research conducted over the last 17 years. Taking all results into consideration, M. charantia, C. indicum, C. cassia, K. galanga, A. vulgaris, and M. elliptica were found to have the highest xanthine oxidase inhibitory potential in vitro. This review suggests further research on the natural xanthine oxidase inhibitors, especially in in vivo studies, clinical studies, investigation of active compounds, safety of the plants as well as the pharmacokinetic and bioavailability studies, which remain to be elucidated.

Author contributions

FA: preparing and writing the manuscript; MA: initiate the process of the review paper; AR, NA, SS, SE: check and comment the manuscript.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer MK and handling Editor declared their shared affiliation.

Acknowledgments

We would like to thank Universiti Tun Hussein Onn Malaysia (UTHM) for providing internal research grant (Vot No. U758; E15501; U673; U908) to fund this research.

References

  1. Abd Aziz S. M., Low C. N., Chai L. C., Abd Razak S. S. N., Selamat J., Son R., et al. (2011). Screening of selected Malaysian plants against several food borne pathogen bacteria. Int. Food Res. J. 18, 1141–1147. [Google Scholar]
  2. Al-Azzawie H. F., Abd S. A. (2015). Effect of some plant extracts on serum uric acid levels and xanthine oxidase activity in vitro and in oxonate-induced hyperuricemic rats. Eur. J. Pharm. Med. Res. 2, 55–61. [Google Scholar]
  3. Alsultanee I. R., Ewadh M. J., Mohammed M. F. (2014). Novel natural anti gout medication extract from Momordica charantia. J. Nat. Sci. Res. 4, 16–23. [Google Scholar]
  4. Apaya K. L., Chichioco-Hern C. L. (2011). Xanthine oxidase inhibition of selected Philippine medicinal plants. J. Med. Plant Res. 5, 289–292. [Google Scholar]
  5. Arafat O. M., Tham S. Y., Sadikun A., Zhari I., Haughton P. J., Asmawi M. Z. (2008). Studies on diuretic and hypouricemic effects of Orthosiphon stamineus methanol extracts in rats. J. Ethnopharmacol. 118, 354–360. 10.1016/j.jep.2008.04.015 [DOI] [PubMed] [Google Scholar]
  6. Azmi S. M. N., Jamal P., Amid A. (2012). Xanthine oxidase inhibitory activity from potential Malaysian medicinal plant as remedies for gout. Int. Food Res. J. 19, 159-165. [Google Scholar]
  7. Bailey P. S., Jr., Bailey C. A. (2000). Organic Chemistry: A Brief Survey of Concepts and Applications. New Jersey, NJ: Pearson Education International; Prentice-Hall Inc [Google Scholar]
  8. Becker M. A., Schumacher H. R., Jr., Wortmann R. L., MacDonald P. A., Eustace D., Palo W. A., et al. (2005). Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N. Engl. J. Med. 353, 2450–2461. 10.1056/NEJMoa050373 [DOI] [PubMed] [Google Scholar]
  9. Bustanji Y., Hudaib M., Tawaha K., Mohammad M. K., Almasri I., Hamed S., et al. (2011). In vitro xanthine oxidase inhibition by selected Jordanian medicinal plants. Jordan J. Pharm. Sci. 4, 49–56. [Google Scholar]
  10. Butterweck V., Khan S. R. (2009). Herbal medicines in the management of urolithiasis: alternative or complementary? Planta Med. 75, 1095–1103. 10.1055/s-0029-1185719 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chao J., Terkeltaub R. (2009). A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout. Curr. Rheumatol. Rep. 11, 135–140. 10.1007/s11926-009-0019-z [DOI] [PubMed] [Google Scholar]
  12. Dalbeth N., Lauterio T. J., Wolfe H. R. (2014). Mechanism of action of colchicine in the treatment of gout. Clin. Ther. 36, 1465–1479. 10.1016/j.clinthera.2014.07.017 [DOI] [PubMed] [Google Scholar]
  13. Dandekar R., Fegade B., Naik A. (2015). Evaluation of anti-inflammatory activity of alcohol and aqueous extract of Epiphyllum oxypetalum leaves. World J. Pharm. Pharm. Sci. 4, 851–858. [Google Scholar]
  14. Ding Z., Dai Y., Wang Z. (2005). Hypouricemic action of scopoletin arising from xanthineoxidase inhibition and uricosuric activity. Planta Med. 71, 183–185. 10.1055/s-2005-837789 [DOI] [PubMed] [Google Scholar]
  15. El-Rahman H. S., Abd–Elhak N. A. (2015). Xanthine oxidase inhibitory activity and antigout of celery leek parsley and molokhia. Adv. Biochem. 3, 40–50. 10.11648/j.ab.20150304.11 [DOI] [Google Scholar]
  16. Enomoto A., Kimura H., Chairoungdua A., Shigeta Y., Jutabha P., Cha S. H., et al. (2002). Molecular identification of a renal urate–anion exchanger that regulates blood urate levels. Nature 417, 447–452. 10.1038/nature742 [DOI] [PubMed] [Google Scholar]
  17. Fadzureena J., Mazura M. P., Adiana M. A., Hani I. B. (2013). An investigation into the inhibitory effect of Senna alata L. leaf extract as well as its isolated compound on xanthine oxidase assay, in Proceedings of the Conference on Forestry and Forest Products Research (Kuala Lumpur: ), 262. [Google Scholar]
  18. Falasca G. F. (2006). Metabolic diseases: gout. Clin. Dermatol. 24, 498–508. 10.1016/j.clindermatol.2006.07.015 [DOI] [PubMed] [Google Scholar]
  19. Fariza I., Fadzureena J., Zunoliza A., Chuah A. L., Pin K. Y., Adawiah I. (2012). Anti-inflammatory activity of the major compound from methanol extract of Phaleria macrocarpa leaves. J. Appl. Sci. 12, 1195–1198. 10.3923/jas.2012.1195.1198 [DOI] [Google Scholar]
  20. Fejes S. Z., Blazovics A., Lemberkovics E., Petri G., Szöke E., Kery A. (2000). Free radical scavenging and membrane protective effects of methanol extracts from Anthriscus cerefolium L.(Hoffm.) and Petroselinum crispum (Mill.) Nym. ex AW Hill. Phytother. Res. 14, 362–365. [DOI] [PubMed] [Google Scholar]
  21. Flemmig J., Kuchta K., Arnhold J., Rauwald H. W. (2011). Olea europaea leaf (Ph. Eur.) extract as well as several of its isolated phenolics inhibit the gout-related enzyme xanthine oxidase. Phytomedicine 18, 561–566. 10.1016/j.phymed.2010.10.021 [DOI] [PubMed] [Google Scholar]
  22. Gliozzi M., Malara N., Muscoli S., Mollace V. (2016). The treatment of hyperuricemia. Int. J. Cardiol. 213, 23–27. 10.1016/j.ijcard.2015.08.087 [DOI] [PubMed] [Google Scholar]
  23. Haidari F., Rashidi M. R., Eshraghian M. R., Mahboob S. A., Shahi M. M., Keshavarz S. A. (2008). Hypouricemic and antioxidant activities of Allium cepa Lilliaceae and quercetin in normal and hyperuricemic rats. Saudi Med. J. 29, 1573–1579. [PubMed] [Google Scholar]
  24. Hendriani R., Sukandar E. Y., Anggadiredja K., Sukrasno (2016). In vitro evaluation of xanthine oxidase inhibitory activity of selected medicinal plants. Int. J. Pharm. Clin. Res. 8, 235–238. [Google Scholar]
  25. Hou C. W., Lee Y. C., Hung H. F., Fu H. W., Jeng K. C. (2012). Longan seed extract reduces hyperuricemia via modulating urate transporters and suppressing xanthine oxidase activity. Am. J.Chin. Med. 40, 979–991. 10.1142/S0192415X12500723 [DOI] [PubMed] [Google Scholar]
  26. Ichida K., Matsuo H., Takada T., Nakayama A., Murakami K., Shimizu T., et al. (2012). Decreased extra-renal urate excretion is a common cause of hyperuricemia, Nat. Commun. 3:764. 10.1038/ncomms1756 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jamal P., Azmi S. M., Amid A., Salleh H. M., Hashim Y. Z. (2014). Development and improvement of anti-gout property from aqueous-methanol extract of Morinda elliptica using central composite design. Adv. Environ. Biol. 8, 734–743. [Google Scholar]
  28. Jiang Y., You X. Y., Fu K. L., Yin W. L. (2012). Effects of extract from Mangifera indica leaf on monosodium urate crystal-induced gouty arthritis in rats. Evid. Based Complement. Alternat. Med. 2012:967573. 10.1155/2012/967573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jothy S. L., Zuraini Z., Sasidharan S. (2011). Phytochemicals screening, DPPH free radical scavenging and xanthine oxidase inhibitiory activities of Cassia fistula seeds extract. J. Med. Plants Res. 5, 1941–1947. [Google Scholar]
  30. Kong L. D., Cai Y., Huang W. W., Cheng C. H., Tan R. X. (2000). Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J. Ethnopharmacol. 73, 199–207. 10.1016/S0378-8741(00)00305-6 [DOI] [PubMed] [Google Scholar]
  31. Kong L. D., Yang C., Ge F., Wang H. D., Guo Y. S. (2004). A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J. Ethnopharmacol. 93, 325–330. 10.1016/j.jep.2004.04.008 [DOI] [PubMed] [Google Scholar]
  32. Kulip J. (2003). An ethnobotanical survey of medicinal and other useful plants of Muruts in Sabah, Malaysia. Telopea 10, 81–98. 10.7751/telopea20035608 [DOI] [Google Scholar]
  33. Kumar A., Azmi W. (2014). Phytomedicine: a novel alternative for treatment of gout. Ann. Phys. Med. 3, 80–88. [Google Scholar]
  34. Kuo C. F., Grainge M. J., Zhang W., Doherty M. (2015). Global epidemiology of gout: prevalence, incidence and risk factors. Nat. Rev. Rheumatol. 11, 649–662. 10.1038/nrrheum.2015.91 [DOI] [PubMed] [Google Scholar]
  35. Kuo C. Y., Kao E. S., Chan K. C., Lee H. J., Huang T. F., Wang C. J. (2012). Hibiscus sabdariffa L. extracts reduce serum uric acid levels in oxonate-induced rats. J. Funct. Foods. 4, 375–381. 10.1016/j.jff.2012.01.007 [DOI] [Google Scholar]
  36. Matsuo H., Chiba T., Nagamori S., Nakayama A., Domoto H., Phetdee K., et al. (2008). Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am. J. Hum. Genet. 83, 744–751. 10.1016/j.ajhg.2008.11.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mirghani M. E. S., Liyana Y., Parveen J. (2012). Bioactivity analysis of lemongrass (Cymbopogan citratus) essential oil. Int. Food. Res. J. 19, 569–575. [Google Scholar]
  38. Mo S. F., Zhou F., Lv Y. Z., Hu Q. H., Zhang D. M., Kong L. D. (2007). Hypouricemic action of selected flavonoids in mice: structure–activity relationships. Biol. Pharm. Bull. 30, 1551–1556. 10.1248/bpb.30.1551 [DOI] [PubMed] [Google Scholar]
  39. Mohamed D. A., Al-Okbi S. Y. (2008). Evaluation of anti-gout activity of some plant food extracts. Pol. J. Food Nutr. Sci. 58, 389–395. [Google Scholar]
  40. Mohd A., Das Gupta E., Loh Y. L., Gandhi C., D'Souza B., Gun S. C. (2011). Clinical characteristics of gout: a hospital case series. Malaysian Fam. Phys. 6, 72–73. [PMC free article] [PubMed] [Google Scholar]
  41. Mujumdar A. M., Misar A. V. (2004). Anti-inflammatory activity of Jatropha curcas roots in mice and rats. J. Ethnopharmacol. 90, 11–15. 10.1016/j.jep.2003.09.019 [DOI] [PubMed] [Google Scholar]
  42. Murata K., Nakao K., Hirata N., Namba K., Nomi T., Kitamura Y., et al. (2009). Hydroxychavicol: a potent xanthine oxidase inhibitor obtained from the leaves of betel, Piper betle. J. Nat. Med. 63, 355–359. 10.1007/s11418-009-0331-y [DOI] [PubMed] [Google Scholar]
  43. Murugaiyah V., Chan K. L. (2009). Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents. J. Ethnopharmacol. 124, 233–239. 10.1016/j.jep.2009.04.026 [DOI] [PubMed] [Google Scholar]
  44. Mutee A. F., Salhimi S. M., Yam M. F., Lim C. P., Abdullah G. Z., Ameer O. Z., et al. (2010). In vivo anti-inflammatory and in vitro antioxidant activities of Peperomia pellucida. Int. J. Pharmacol. 6, 686–690. 10.3923/ijp.2010.686.690 [DOI] [Google Scholar]
  45. Nessa F., Ismail Z., Mohamed N. (2010). Xanthine oxidase inhibitory activities of extracts and flavonoids of the leaves of Blumea balsamifera. Pharm. Biol. 48, 1405–1412. 10.3109/13880209.2010.487281 [DOI] [PubMed] [Google Scholar]
  46. Nguyen M. T. T., Awale S., Tezuka Y., Le Tran Q., Watanabe H., Kadota S. (2004). Xanthine oxidase inhibitory activity of Vietnamese medicinal plants. Biol. Pharm. Bull. 27, 1414–1421. 10.1248/bpb.27.1414 [DOI] [PubMed] [Google Scholar]
  47. Nile S. H., Khobragade C. N. (2011). In vitro anti-inflammatory and xanthine oxidase inhibitory activity of Tephrosia purpurea shoot extract. Nat. Prod. Commun. 6, 1437–1440. [PubMed] [Google Scholar]
  48. Nile S. H., Kumar B., Park S. W. (2013). In vitro evaluation of selected benzimidazole derivatives as an antioxidant and xanthine oxidase inhibitors. Chem. Biol. Drug Des. 82, 290–295. 10.1111/cbdd.12141 [DOI] [PubMed] [Google Scholar]
  49. Nile S. H., Park S. W. (2014). HPTLC analysis, antioxidant and antigout activity of Indian plants. Iran, J. Pharm. Res. 13, 531. [PMC free article] [PubMed] [Google Scholar]
  50. Nishiura J. L., Campos A. H., Boim M. A., Heilberg I. P., Schor N. (2004). Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urol. Res. 32, 362–366. 10.1007/s00240-004-0432-8 [DOI] [PubMed] [Google Scholar]
  51. Offermanns S., Rosenthal W. (2008). Encyclopedia of Molecular Pharmacology. New York, NY: Springer. [Google Scholar]
  52. Orech F. O., Akenga T., Ochora J., Friis H., Aagaard-Hansen J. (2005). Potential toxicity of some traditional leafy vegetables consumed in Nyang'oma Division, Western Kenya. Afr. J. Food Agric. Nutr. Dev. 5, 1–13. [Google Scholar]
  53. Osman N. I., Sidik N. J., Awal A., Adam N. A. M., Rezali N. I. (2016). In vitro xanthine oxidase and albumin denaturation inhibition assay of Barringtonia racemosa L. and total phenolic content analysis for potential anti-inflammatory use in gouty arthritis. J. Intercult. Ethnopharmacol. 5, 343–349. 10.5455/jice.20160731025522 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Pacher P., Nivorozhkin A., Szabó C. (2006). Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev. 58, 87–114. 10.1124/pr.58.1.6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Palu A., Deng S., West B., Jensen J. (2009). Xanthine oxidase inhibiting effects of noni (Morinda citrifolia) fruit juice. Phytother. Res. 23, 1790–1791. 10.1002/ptr.2842 [DOI] [PubMed] [Google Scholar]
  56. Pillinger M. H., Rosenthal P., Abeles A. M. (2007). Hyperuricemia and gout: new insights into pathogenesis and treatment. Bull. NYU Hosp. Jt. Dis. 65, 215–215. [PubMed] [Google Scholar]
  57. Prasongwatana V., Woottisin S., Sriboonlue P., Kukongviriyapan V. (2008). Uricosuric effect of Roselle (Hibiscus sabdariffa) in normal and renal-stone former subjects. J. Ethnopharmacol. 117, 491–495. 10.1016/j.jep.2008.02.036 [DOI] [PubMed] [Google Scholar]
  58. Premgamone A., Sriboonlue P., Disatapornjaroen W., Maskasem S., Sinsupan N., Apinives C. (2001). A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Southeast Asian J. Trop. Med. Public Health. 32, 654–660. [PubMed] [Google Scholar]
  59. Sri-Wahjuni Putra-Manuaba I. B., Rahayu-Artini N. P., Wahyu-Dwijani S. (2012). Uric acid inhibition activity of Annona muricata L. leave extract in hyperuricemia induced wistar rat. Adv. Pure and Appl. Chem. 2, 86–90. [Google Scholar]
  60. RadakPerović M., ZlatkovićŠvenda M. (2013). The efficacy and tolerability of allopurinol dose escalation in patients with gout. Srpski arhiv za celokupno lekarstvo, 141, 333–336. 10.2298/SARH1306333R [DOI] [PubMed] [Google Scholar]
  61. Rajendran R., Krishnakumar E. (2010). Anti-arthritic activity of Premna serratifolia Linn., wood against adjuvant induced arthritis. Avicenna J. Med. Biotechnol. 2, 101–106. [PMC free article] [PubMed] [Google Scholar]
  62. Raju R., Joseph S., Scria S., Mathews S. M., Umamheshwari M. (2012). Effect of the fractions of Erythrina stricta leaf extract on serum urate levels and Xo/Xdh activities in oxonate-induced hyperuricaemic mice. J. Appl. Pharm. Sci. 2, 89–94. [Google Scholar]
  63. Rates S. M. K. (2001). Plants as source of drugs. Toxicon 39, 603–613. 10.1016/S0041-0101(00)00154-9 [DOI] [PubMed] [Google Scholar]
  64. Roddy E., Doherty M. (2010). Gout. Epidemiology of gout. Arthritis Res. Ther. 12:223. 10.1186/ar3199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Roohbakhsh A., Shamsara J., Khayyat M. H., Karimi G. (2009). Inhibition of xanthine oxidase by some Iranian plant remedies used for gout. Pharmacologyonline. 3, 1031–1036. [Google Scholar]
  66. Sabina E. P., Nagar S., Rasool M. (2011). A role of piperine on monosodium urate crystal-induced inflammation—an experimental model of gouty arthritis. Inflammation 34, 184–192. 10.1007/s10753-010-9222-3 [DOI] [PubMed] [Google Scholar]
  67. Sabina E. P., Rasool M. (2008). An in vivo and in vitro potential of Indian ayurvedic herbal formulation Triphala on experimental gouty arthritis in mice. Vasc. Pharmacol. 48, 14–20. 10.1016/j.vph.2007.11.001 [DOI] [PubMed] [Google Scholar]
  68. Sarvaiya V. N., Sadariya K. A., Pancha P. G., Thaker A. M., Patel A. C., Prajapati A. S. (2015). Evaluation of antigout activity of Phyllanthus emblica fruit extracts on potassium oxonate-induced gout rat model. Vet. World 8, 1230–1236. 10.14202/vetworld.2015.1230-1236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Sheu S. Y., Fu Y. T., Huang W. D., Chen Y. A., Lei Y. C., Yao C. H., et al. (2016). Evaluation of xanthine oxidase inhibitory potential and in vivo hypouricemic activity of Dimocarpus longan lour. extracts. Pharmacogn. Mag. 12, 206–212. 10.4103/0973-1296.182176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Shi Y. C., Lin K. S., Jhai Y. F., Lee B. H., Han Y., Cui Z., et al. (2016). Miracle fruit (Synsepalum dulcificum) exhibits as a novel anti-hyperuricaemia agent. Molecules 21:140. 10.3390/molecules21020140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Shi Y. W., Wang C. P., Wang X., Zhang Y. L., Liu L., Wang R. W., et al. (2012). Uricosuric and nephroprotective properties of Ramulus Mori ethanol extract in hyperuricemic mice. J. Ethnopharmacol. 143, 896–904. 10.1016/j.jep.2012.08.023 [DOI] [PubMed] [Google Scholar]
  72. Somchit M. N., Mak J. H., Bustamam A. A., Zuraini A., Arifah A. K., Adam Y., et al. (2012). Zerumbone isolated from Zingiber zerumbet inhibits inflammation and pain in rats. J. Med. Plants Res. 6, 177–180. 10.5897/JMPR10.492 [DOI] [Google Scholar]
  73. Sowndhararajan K., Joseph J. M., Rajendrakumaran D. (2012). In vitro xanthine oxidase inhibitory activity of methanol extracts of Erythrina indica Lam. leaves and stem bark. Asian Pac. J. Trop. Biomed. 2, 1415–S1417. 10.1016/S2221-1691(12)60428-6 [DOI] [Google Scholar]
  74. Sreeramulu D., Raghunath M. (2010). Antioxidant activity and phenolic content of roots, tubers and vegetables commonly consumed in India. Food Res. Int. 43, 1017–1020. 10.1016/j.foodres.2010.01.009 [DOI] [Google Scholar]
  75. Srivastava S., Lal V. K., Pant K. K. (2012). Polyherbal formulations based on Indian medicinal plants as antidiabetic phytotherapeutics. Phytopharmacology 2, 1–5. [Google Scholar]
  76. Stamp L. K., O'Donnell J. L., Chapman P. T. (2007). Emerging therapies in the long-termmanagement of hyperuricaemia and gout. Intern. Med. J. 37, 258–266. 10.1111/j.1445-5994.2007.01315.x [DOI] [PubMed] [Google Scholar]
  77. Strazzullo P., Puig J. G. (2007). Uric acid and oxidative stress: relative impact on cardiovascular risk. Nutr. Metab. Cardiovasc. Dis. 17, 409–414. 10.1016/j.numecd.2007.02.011 [DOI] [PubMed] [Google Scholar]
  78. Sunarni T., Leviana F., Fidrianny I., Iwo M. I., Wirasutisna K. R. (2015). Antihyperuricemic activity of four plants Annonaceae using hyperuricemic rats model and enzyme assay. Asian J. Pharm. Clin. Res. 8, 250–253. [Google Scholar]
  79. Sungthong B., Manok S., Sato H., Sato V. H. (2016). Effects of Aquilaria Crassna on xanthine oxidase activity in vitro and hyperuricemic mice. Indian J. Pharm. Sci. 78, 547–552. 10.4172/pharmaceutical-sciences.1000151 [DOI] [Google Scholar]
  80. Tan M. J., Ye J. M., Turner N., Hohnen-Behrens C., Ke C. Q., Tang C. P., et al. (2008). Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem. Biol. 15, 263–273. 10.1016/j.chembiol.2008.01.013 [DOI] [PubMed] [Google Scholar]
  81. Tapsell L. C., Hemphill I., Cobiac L., Sullivan D. R., Fenech M., Patch C. S., et al. (2006). Supplement-health benefits of herbs and spices: the past, the present, the future. Med. J. Aust. 185, 4–24. [DOI] [PubMed] [Google Scholar]
  82. Tausche A. K., Jansen T. L., Schröder H. E., Bornstein S. R., Aringer M., Müller-Ladner U. (2009). Gout—current diagnosis and treatment. Dtsch. Arztebl. Int. 106, 549–555. 10.3238/arztebl.2009.0549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Teh C. L., Chew K. F., Ling G. R. (2014). Acute gout in hospitalized patients in Sarawak general hospital. Med. J. Malaysia 69, 126–128. [PubMed] [Google Scholar]
  84. Triggiani V., Resta F., Guastamacchia E., Sabbà C., Licchelli B., Ghiyasaldin S., et al. (2006). Role of antioxidants, essential fatty acids, carnitine, vitamins, phytochemicals and trace elements in the treatment of diabetes mellitus and its chronic complications. Endocr. Metab. Immune Disord. Drug Targets 6, 77–93. 10.2174/187153006776056611 [DOI] [PubMed] [Google Scholar]
  85. Tu S. F., Liu R. H., Cheng Y. B., Hsu Y. M., Du Y. C., El-Shazly M., et al. (2014). Chemical constituents and bioactivities of Clinacanthus nutans aerial parts. Molecules 19, 20382–20390. 10.3390/molecules191220382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Umamaheswari M., Asokkumar K., Sivashanmugam A. T., Remyaraju A., Subhadradevi V., Ravi T. K. (2009). In vitro xanthine oxidase inhibitory activity of the fractions of Erythrina stricta Roxb. J. Ethnopharmacol. 124, 646–648. 10.1016/j.jep.2009.05.018 [DOI] [PubMed] [Google Scholar]
  87. Umamaheswari M., AsokKumar K., Somasundaram A., Sivashanmugam T., Subhadradevi V., Ravi T. K. (2007). Xanthine oxidase inhibitory activity of some Indian medical plants. J. Ethnopharmacol. 109, 547–551. 10.1016/j.jep.2006.08.020 [DOI] [PubMed] [Google Scholar]
  88. Unno T., Sugimoto A., Kakuda T. (2004). Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers. J. Ethnopharmacol. 93, 391–395. 10.1016/j.jep.2004.04.012 [DOI] [PubMed] [Google Scholar]
  89. Wahyuningsih S., Sukandar E. Y., Sukrasno (2016a). Antihyperuricemia activity of the ethanol extract of Roselle calyx and its fraction (Hibiscus sabdariffa Linn) on male wistar rats. Int. J. Pharm. Pharm. Sci. 8, 278–280. [Google Scholar]
  90. World Health Organization (2011). The World Traditional Medicines Situation, in Traditional Medicines: Global Situation, Issues and Challenges. Geneva 3, 1–14. [Google Scholar]
  91. Wahyuningsih S., Sukandar E. Y., Sukrasno (2016b). In vitro xanthine oxidase inhibitor activity of ethanol extract and fraction roselle calyx (Hibiscus sabdariffa L.). Int. J. Pharma. Clin. Res. 94, 5–35. [Google Scholar]
  92. Wang Y., Zhu J. X., Kong L. D., Yang C., Cheng C. H. K., Zhang X. (2004). Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice. Basic Clin. Pharmacol. Toxicol. 94, 232–237. 10.1111/j.1742-7843.2004.pto940506.x [DOI] [PubMed] [Google Scholar]
  93. Wong Y. P., Ng R. C., Chuah S. P., Koh R. Y., Ling A. P. K. (2014). Antioxidant and xanthine oxidase inhibitory activities of Swietenia macrophylla and Punica granatum, in International Conference on Biological, Environment and Food Engineering (Bali: ). [Google Scholar]
  94. Yang H., Gao L., Niu Y., Zhou Y., Lin H., Jiang J., et al. (2015). Mangiferin inhibits renal urate reabsorption by modulating urate transporters in experimental hyperuricemia. Biol. Pharm. Bull. 38, 1591–1598. 10.1248/bpb.b15-00402 [DOI] [PubMed] [Google Scholar]
  95. Yan M., An Y. T., Li J., Wu Z. Z., Wang T. (2014). Regulatory effect of leonurus extracts on hyperuricemia in rats. China J. Chin. Mater. Med. 39, 4856–4859. [PubMed] [Google Scholar]
  96. Yumita A., Suganda A. G., Sukandar E. Y. (2013). Xanthine oxidase inhibitory activity of some Indonesian medicinal plants and active fraction of selected plants. Int. J. Pharmacy Pharm. Sci. 5, 293–296. [Google Scholar]
  97. Zeng Y. C., Li S., Liu C., Gong T., Sun X., Fu Y., et al. (2017). Soluplus micelles forimproving the oral bioavailability of scopoletin and their hypouricemic effect in vivo. Acta Pharmacol. Sin. 38, 424–433. 10.1038/aps.2016.126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Zhang J., Shuai X., Li J., Xiang N., Gong T., Zhang Z. (2016). Biodistribution, hypouricemic efficacy and therapeutic mechanism of morin phospholipid complex loaded self-nanoemulsifying drug delivery systems in an experimental hyperuricemic model in rats. J. Pharm. Pharmacol. 68, 14–25. 10.1111/jphp.12492 [DOI] [PubMed] [Google Scholar]
  99. Zhang Y., Jin L., Liu J., Wang W., Yu H., Li J., et al. (2017). Regulation mechanism of Dioscin on uric acid excretion. J. Ethnopharmacol. 214, 29–36. 10.1016/j.jep.2017.12.004 [DOI] [PubMed] [Google Scholar]
  100. Zhou K., Yu L. (2006). Total phenolic contents and antioxidant properties of commonly consumed vegetables grown in Colorado. Food Sci. Technol. 39, 1155–1162. 10.1016/j.lwt.2005.07.015 [DOI] [Google Scholar]

Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES